Page last updated: 2024-11-05

thalidomide and Disbacteriosis

thalidomide has been researched along with Disbacteriosis in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research Excerpts

ExcerptRelevanceReference
"Thalidomide is an important immunomodulatory and antitumor drug and its effects on the gut microbiota still remain unclear."1.72A metagenome-wide association study of the gut microbiota in recurrent aphthous ulcer and regulation by thalidomide. ( Duan, N; Hu, Q; Huang, F; Huang, J; Jiang, H; Lin, L; Liu, Q; Qian, Y; Ruan, H; Song, Y; Wang, W; Wang, X; Xiong, K; Yan, F; Ye, P; Zhao, M; Zheng, L; Zhu, Y, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, X1
Xiong, K1
Huang, F1
Huang, J1
Liu, Q1
Duan, N1
Ruan, H1
Jiang, H1
Zhu, Y1
Lin, L1
Song, Y1
Zhao, M1
Zheng, L1
Ye, P1
Qian, Y1
Hu, Q1
Yan, F1
Wang, W1

Other Studies

1 other study available for thalidomide and Disbacteriosis

ArticleYear
A metagenome-wide association study of the gut microbiota in recurrent aphthous ulcer and regulation by thalidomide.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Dysbiosis; Gastrointestinal Microbiome; Humans; Metagenome; Stomatitis, Aphthous; Thalidomide

2022